Leyden Laboratories B.V. (the "Company" or "Leyden Labs") today announced it has raised $70M in funding to advance its Mucosal Protection Platform. This non-vaccine approach utilizes broadly ...

Amsterdam-based Leyden Labs, a platform working to free people from the threat of respiratory viruses, announced Thursday that it has raised $70M (approximately €68M) in funding. The funding round was ...

A Dutch biotech cre­at­ing nasal sprays to pro­tect against the flu and coro­n­avirus has raised an ad­di­tion­al $70 mil­lion and ac­quired a nim­ble Sin­ga­pore start­up … ...

Credit: Aaron of L.A. Photography/Shutterstock Credit: Aaron of L.A. Photography/Shutterstock ...